154 related articles for article (PubMed ID: 16624339)
1. Enhanced proangiogenic signaling in thrombospondin-1-deficient retinal endothelial cells.
Wang Y; Wang S; Sheibani N
Microvasc Res; 2006 May; 71(3):143-51. PubMed ID: 16624339
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 deficient mice exhibit an altered expression pattern of alternatively spliced PECAM-1 isoforms in retinal vasculature and endothelial cells.
Wang Y; Su X; Wu Z; Sheibani N
J Cell Physiol; 2005 Jul; 204(1):352-61. PubMed ID: 15672414
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of murine retinal endothelial cells.
Su X; Sorenson CM; Sheibani N
Mol Vis; 2003 May; 9():171-8. PubMed ID: 12740568
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of retinal vascular development and neovascularization in transgenic mice over-expressing thrombospondin-1 in the lens.
Wu Z; Wang S; Sorenson CM; Sheibani N
Dev Dyn; 2006 Jul; 235(7):1908-20. PubMed ID: 16691615
[TBL] [Abstract][Full Text] [Related]
5. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina.
Sun J; Hopkins BD; Tsujikawa K; Perruzzi C; Adini I; Swerlick R; Bornstein P; Lawler J; Benjamin LE
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1344-51. PubMed ID: 19304944
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
[TBL] [Abstract][Full Text] [Related]
8. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
9. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.
Guo N; Krutzsch HC; Inman JK; Roberts DD
Cancer Res; 1997 May; 57(9):1735-42. PubMed ID: 9135017
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of corneal endothelial cells from wild type and thrombospondin-1 deficient mice.
Scheef EA; Huang Q; Wang S; Sorenson CM; Sheibani N
Mol Vis; 2007 Aug; 13():1483-95. PubMed ID: 17893672
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
Kou B; Ni J; Vatish M; Singer DR
Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
[TBL] [Abstract][Full Text] [Related]
15. Alterations in cell-adhesive and migratory properties of proximal tubule and collecting duct cells from bcl-2 -/- mice.
Ziehr J; Sheibani N; Sorenson CM
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1154-63. PubMed ID: 15292044
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration.
Wang S; Wu Z; Sorenson CM; Lawler J; Sheibani N
Dev Dyn; 2003 Dec; 228(4):630-42. PubMed ID: 14648840
[TBL] [Abstract][Full Text] [Related]
17. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor.
Isenberg JS; Calzada MJ; Zhou L; Guo N; Lawler J; Wang XQ; Frazier WA; Roberts DD
Matrix Biol; 2005 Apr; 24(2):110-23. PubMed ID: 15890262
[TBL] [Abstract][Full Text] [Related]
18. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.
Ridnour LA; Isenberg JS; Espey MG; Thomas DD; Roberts DD; Wink DA
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13147-52. PubMed ID: 16141331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
